Mylan receives FDA approval for generic Hyzaar, Wellbutrin SR

04/12/2010 | American City Business Journals

Mylan gained FDA approval to market generic formulations of Merck & Co.'s blood pressure drug Hyzaar and GlaxoSmithKline's antidepressant Wellbutrin SR. The generic-drug firm has started shipping the products, known as losartan potassium and hydrochlorothiazide tablets and bupropion hydrochloride extended-release tablets, respectively.

View Full Article in:

American City Business Journals